Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Asia Pacific (Supplemental) | 2024

The Asia Pacific GI endoscopy device market was negatively impacted by the COVID-19 pandemic. Following recovery, the market will grow moderately throughout the forecast period, mainly due to the high incidence of gastric cancer and CRC cases in the region, the increasing uptake of GI endoscopy devices among physicians due to training programs and conferences, and the improving healthcare infrastructure.

This Medtech 360 Report provides high-level market metrics for the GI endoscopy device market in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific from 2019 through 2032.

Related Medtech Insights Reports

Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…
Report
Large-Joint Reconstructive Implants – Market Insights – Asia Pacific
The Asia Pacific large-joint reconstructive implant market is experiencing moderate growth driven by an increasing number of elective procedures, a rising elderly population affected by arthritis…
Report
Gynecological Devices – Market Insights – Asia Pacific
Driven by the rising prevalence of gynecological diseases and aging population in this region, the Asia Pacific gynecological device market will continue to witness modest growth through 2034…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…